Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Post-market follow-up: Breast surgery outcomes with Stryker devices

Official title: A Retrospective, Multi-center, Post-market Registry Study of Surgical Procedures in Endoscopy, Breast, and Urology (PROspect)

Run by Stryker Endoscopy · NCT07631468 · Data updated 2026-11-12

This registry collects real-world outcomes after breast surgeries using Stryker devices to see how patients do over time.

More Breast Surgery trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorStryker Endoscopy
Industry-sponsored
Locations2 sites (Jacksonville, Florida and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedMay 1, 2031
Study endsDecember 1, 2031
Registry record updatedAugust 19, 2026
Trial IDNCT07631468 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) who underwent breast surgical procedures using MOLLI, SPY-PHI, or SPY AGENT GREEN.

Probably not a fit

Patients who do not receive follow-up data or who had surgery before January 2022 may have limited insights from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective, multi-center observational registry that uses data from standard clinical care to document outcomes after breast procedures performed with MOLLI, SPY-PHI, or SPY AGENT GREEN. The study gathers clinical outcomes and patient-reported outcomes where applicable, focusing on safety and performance of the devices in routine practice. Data come from chart reviews and existing medical records, without any additional interventions beyond standard care. Eligible participants are adults who had breast surgery with the specified Stryker devices, with follow-up occurring at least one month post-procedure. The initiative helps characterize real-world safety signals and patient experiences related to these devices.

Why it matters

Potential benefit: If successful, the registry could clarify real-world safety and effectiveness of the devices in routine breast surgery.

How similar studies have gone: Observational registries with standard-of-care data have provided useful safety and outcome insights in other device-related procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject was ≥ 18 years of age at the time of the surgery
* Patients who have undergone breast surgical procedures using MOLLI, SPY-PHI, and/or SPY AGENT GREEN

Exclusion Criteria:

* Subjects who are less than 1-month post-intervention
* Concurrent participation in an interventional investigational clinical study at the time of initial surgery
* Subjects whose surgery date was prior to January 2022.
* Pregnant or lactating females at the time of initial surgery

Where it's running

  • MD Baptist MD Anderson
    Jacksonville, Florida, United States
    Recruiting
  • Tufts Medical Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.